An open-ended scheme replicating / tracking NIFTY50 Equal Weight Total Return Index [TRI]| Data as on 31 January 2024
| Investment Objective The investment objective of the scheme is to provide returns that, before expenses, corresponds to the total return of the securities as represented by the underlying index, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved. |
|||||||||
| Inception Date |
7th June 2023 | ||||||||
| Fund Manager |
Mr. Sharwan Kumar Goyal, B.Com, MMS, CFA Managing the scheme since June 7, 2023 Mr. Ayush Jain, Asst. Fund Manager, B.com (Tax), C.A |
||||||||
| Fund AUM |
Fund Size Monthly Average : 57.54 Crore Closing AUM : 59.40 Crore |
||||||||
| High/Low NAV in the month |
High Growth Option : 12.3709 Crore Low Growth Option : 12.0092 Crore |
||||||||
Total expense ratio (%) |
Regular : 1.00 Direct : 0.55 |
||||||||
Minimum Investment Amount |
5000/- subsequent minimum investment under a folio is 1000/- and in multiples of 1/- thereafter with no upper limit | ||||||||
Plans/Options
(Regular / Direct) |
Growth Option | ||||||||
| Market Capitalisation (%) |
|
||||||||
Load Structure |
Entry Load : Nil Exit Load : Nil *In terms of SEBI circular no. SEBI/IMD/CIR No.4/168230/09 dated June 30, 2009, no entry load will be charged by the Scheme to the investor effective August 1, 2009 |
||||||||
NAV per unit as on 31st January, 2024 |
Regular Growth Option 12.3614 Direct Growth Option 12.4032 |
||||||||
Benchmark Index |
NIFTY50 Equal Weight TRI | ||||||||
| Financial Services | 19% |
| Automobile and Auto Components | 13% |
| Information Technology | 12% |
| Healthcare | 10% |
| Fast Moving Consumer Goods | 10% |
| % of Top 10 Stocks | 22.46 |
| Median Market Cap ( Cr) | 259,769 |
| Weighted Average Market Cap | 347,561 |
| Number of Securities | 50 |
| All figures given are provisional and unaudited. |
|
Equity
|
% of NAV
|
| Tata Motors Ltd. | 2.38 |
| Oil & Natural Gas Corporation Ltd. | 2.36 |
| Bajaj Auto Ltd. | 2.30 |
| Adani Ports And Special Economic Zone Ltd | 2.27 |
| Bharti Airtel Ltd. | 2.27 |
| Sun Pharmaceuticals Industries Ltd. | 2.20 |
| Hero Motocorp Ltd. | 2.20 |
| Apollo Hospitals Enterprise Ltd. | 2.18 |
| Bharat Petroleum Corporation Ltd. | 2.15 |
| Power Grid Corporation Of India Ltd | 2.15 |
| Tata Consumer Products Ltd | 2.15 |
| Coal India Ltd. | 2.15 |
| Reliance Industries Ltd. | 2.14 |
| Adani Enterprises Ltd. | 2.12 |
| Dr Reddy's Laboratories Ltd. | 2.10 |
| Cipla Ltd. | 2.10 |
| HCL Technologies Ltd. | 2.09 |
| Infosys Ltd. | 2.08 |
| Grasim Industries Ltd. | 2.03 |
| Tech Mahindra Ltd | 2.01 |
| ICICI Bank Ltd | 2.00 |
| NTPC Ltd. | 1.99 |
| Wipro Ltd. | 1.97 |
| Ultratech Cement Ltd. | 1.97 |
| Titan Company Ltd. | 1.96 |
| Tata Steel Ltd. | 1.95 |
| Tata Consultancy Services Ltd. | 1.95 |
| SBI Life Insurance Company Ltd. | 1.94 |
| State Bank Of India | 1.94 |
| Hindalco Industries Ltd. | 1.93 |
| Others | 36.88 |
| Net Current Assets | 0.07 |
| TOTAL | 100.00 |
| Fund Performance Vs Benchmark (CAGR) as on 31st January, 2024 Growth of 10000 |
||||||
| Period | NAV Growth (%) |
NIFTY50 Equal Weight TRI (%) |
Nifty 50 TRI (%) |
NAV Growth TRI () |
NIFTY50 Equal Weight TRI (Rs.) |
Nifty 50 TRI () |
| 6 Months | 34.29 |
39.94 |
21.01 |
11,710 |
11,991 |
11,048 |
| SI* | 38.33 |
35.29 |
27.44 |
12,478 |
12,282 |
11,774 |
Different plans have a different expense structure. The performance details provided herein are of regular plan.
Returns less than 1 year are Simple Annualized Growth Rate
For performance details of other Schemes managed by the Fund Manager, please refer the respective Scheme
Please click here in ‘Fund Manager Summary’.
No of Schemes Managed by Mr. Sharwan Kumar Goyal & Mr Ayush Jain.
The performance of the benchmark is calculated using total return index variant of the benchmark index. Load is not taken into consideration for computation of performance.
*Investors should consult their Mutual Fund Distributor if in doubt about whether the product is suitable for them.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.